summary
Introduced
02/07/2024
02/07/2024
In Committee
04/05/2024
04/05/2024
Crossed Over
Passed
Dead
01/08/2025
01/08/2025
Introduced Session
Potential new amendment
103rd General Assembly
Bill Summary
Amends the Prior Authorization Reform Act. Provides that a health insurance issuer may not require prior authorization for a prescription drug prescribed to a patient by a health care professional for 6 or more consecutive months, regardless of whether the prescription drug is a non-preferred medication pursuant to the patient's health insurance coverage; or for specified prescription drugs, including insulin, human immunodeficiency virus prevention medication; human immunodeficiency virus treatment medication; viral hepatitis medication; estrogen; and progesterone.
AI Summary
This bill amends the Prior Authorization Reform Act to prohibit health insurance issuers from requiring prior authorization for certain prescription drugs, including insulin, HIV prevention and treatment medications, viral hepatitis medications, estrogen, and progesterone. Specifically, the bill states that issuers cannot require prior authorization for a prescription drug prescribed to a patient by a healthcare professional for 6 or more consecutive months, regardless of whether the drug is a non-preferred medication under the patient's health insurance coverage.
Committee Categories
Health and Social Services
Sponsors (6)
Jenn Ladisch Douglass (D)*,
Mary Beth Canty (D),
Kelly Cassidy (D),
Margaret Croke (D),
Lilian Jiménez (D),
Gregg Johnson (D),
Last Action
Session Sine Die (on 01/07/2025)
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://www.ilga.gov/legislation/BillStatus.asp?DocNum=5051&GAID=17&DocTypeID=HB&SessionID=112&GA=103 |
| House Amendment 001 | https://www.ilga.gov/legislation/103/HB/10300HB5051ham001.htm |
| BillText | https://www.ilga.gov/legislation/103/HB/10300HB5051.htm |
Loading...